FDA Approved the First 'Digital Medicine System'

In November, the FDA approved the first “digital medicine system” from Ostuka and Proteus in the form of Abilify MyCite, Otsuka’s antipychostic medication embedded with an ingestible sensor from Proteus that can show if a medication has been digested. The sensor had been “approved” since 2012 by the FDA to be included in the clinical trials, but in the drug’s public debut, interesting opinions emerged. The New York Times’ “First Digital Pill Approved to Worries About Biomedical Big Brother” (view here) is certainly an attention-grabber, and the article did bring up legitimate questions, specifically around ethics, compliance, and trust, as well as some interesting views around the patient population. 

Read More